STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] OraSure Technologies Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Earnest Partners, LLC filed Amendment No. 1 to a Schedule 13G reporting its holdings of OraSure Technologies, Inc. (OSUR) common stock. The amendment states Earnest Partners beneficially owned 795 shares, representing 0.0% of the class, and that it ceased to own more than 5% of the issuer as of December 31, 2022. The filing notes it was submitted late due to an inadvertent oversight and affirms the shares were not held with any control intent. The amendment is signed by the firm’s Chief Compliance Officer on 09/03/2025.

Positive
  • Corrective disclosure filed to update ownership status and timing
  • Affirmation of non-control intent clarifies no attempt to influence issuer control
Negative
  • Late filing admitted due to an inadvertent oversight
  • Limited information on prior holdings or transactions; no trading dates provided

Insights

TL;DR Amendment reports a de minimis, non-control holding (795 shares, 0.0%) and corrects a late filing.

Earnest Partners’ current reported stake is immaterial to OraSure’s capitalization and unlikely to affect valuation or governance. The filing clarifies ownership levels and confirms ordinary-course investment intent rather than a control purpose. No trading activity, acquisition dates, or prior larger holdings are disclosed here, so material investor impact is limited.

TL;DR The amendment remedies a late disclosure; compliance note but no material control concerns.

The filing admits a late submission due to inadvertent oversight and certifies that the holdings were not for control purposes. This is a routine corrective disclosure; it raises a procedural compliance issue but provides required investor transparency. There is no indication of regulatory sanctions or contested facts within the statement itself.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: This Amendment No. 1 to Schedule 13G is being filed by EARNEST Partners, LLC to reflect that the reporting person ceased to own more than 5% of the outstanding shares of the issuer as of December 31, 2022. At no time prior to that date, or subsequent to that date, has the reporting person held any of the shares of the issuer with a control intent. The filing is late due to an inadvertent oversight.


SCHEDULE 13G



EARNEST PARTNERS LLC
Signature:James M. Wilson
Name/Title:Chief Compliance Officer
Date:09/03/2025

FAQ

What stake did Earnest Partners report in OraSure (OSUR)?

The amendment reports 795 shares beneficially owned, representing 0.0% of the class.

When did Earnest Partners cease to own more than 5% of OSUR?

The filing states Earnest Partners ceased to own more than 5% of the outstanding shares as of December 31, 2022.

Was the Schedule 13G/A filed on time?

No. The amendment notes the filing is late due to an inadvertent oversight.

Does Earnest Partners claim control over OraSure?

No. The filing explicitly states the shares were not acquired or held for the purpose of changing or influencing control of the issuer.

Who signed the amendment and when?

The document is signed by James M. Wilson, Chief Compliance Officer of Earnest Partners LLC, dated 09/03/2025.
Orasure Tech

NASDAQ:OSUR

OSUR Rankings

OSUR Latest News

OSUR Latest SEC Filings

OSUR Stock Data

200.40M
69.39M
4.91%
92.74%
5.13%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
BETHLEHEM